Golden State Wealth Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$272K Buy
11,293
+1,080
+11% +$28.3K 0.02% 369
2026
Q1
$287K Sell
10,213
-3,527
-26% -$93.9K 0.03% 331
2025
Q4
$342K Sell
13,740
-4,026
-23% -$102K 0.04% 309
2025
Q3
$453K Sell
17,766
-8,691
-33% -$215K 0.05% 254
2025
Q2
$641K Sell
26,457
-5,481
-17% -$128K 0.08% 192
2025
Q1
$809K Sell
31,938
-382
-1% -$10K 0.12% 147
2024
Q4
$857K Buy
+32,320
New +$877K 0.13% 132
2022
Q1
$642K Sell
12,402
-13,525
-52% -$702K 0.13% 150
2021
Q4
$1.53M Buy
25,927
+11,926
+85% +$591K 0.26% 72
2021
Q3
$602K Sell
14,001
-112
-0.8% -$4.96K 0.13% 144
2021
Q2
$553K Buy
14,113
+1,912
+16% +$74.4K 0.12% 150
2021
Q1
$442K Sell
12,201
-10,874
-47% -$386K 0.15% 112
2020
Q4
$849K Buy
23,075
+6,837
+42% +$251K 0.25% 81
2020
Q3
$565K Sell
16,238
-19,591
-55% -$687K 0.19% 88
2020
Q2
$1.11M Buy
35,829
+23,606
+193% +$802K 0.29% 68
2020
Q1
$379K Buy
12,223
+4,644
+61% +$158K 0.17% 92
2019
Q4
$282K Sell
7,579
-3,324
-30% -$118K 0.05% 43
2019
Q3
$372K Buy
10,903
+674
+7% +$24.5K 0.12% 138
2019
Q2
$420K Sell
10,229
-121
-1% -$4.8K 0.13% 135
2019
Q1
$417K Buy
+10,350
New +$414K 0.14% 135

Other funds holding PFE

Golden State Wealth Management's PFE Position: Q2 2026 in Review

Golden State Wealth Management increased its Pfizer (PFE) stake by 11% in Q2 2026, buying an estimated $28.3K and bringing the position to 11,293 shares worth $272K. The position accounts for 0.02% of the portfolio, ranked #369.

Golden State Wealth Management first reported a position in PFE in Q1 2019 and has held it in 20 quarters since. The position peaked at $1.53M in Q4 2021. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Golden State Wealth Management held 11,293 shares of Pfizer worth $272K as of Q2 2026.
  • Golden State Wealth Management bought 1,080 Pfizer shares in Q2 2026, an estimated $28.3K.
  • Pfizer made up 0.02% of Golden State Wealth Management's portfolio in Q2 2026, its #369 holding.
  • Golden State Wealth Management first reported a position in Pfizer in Q1 2019 and has held it in 20 quarters since.
  • Golden State Wealth Management's Pfizer position peaked at $1.53M in Q4 2021.
  • 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Golden State Wealth Management's 13F filing for Q2 2026, filed 22 Jul 2026.